ADMA Biologics Inc (ADMA) — Capital Reinvestment Ratio
Latest as of March 2026:
0.04x
ADMA Biologics Inc (ADMA) has a Capital Reinvestment Ratio of 0.04x as of March 2026, meaning it reinvests 0% of its operating cash flow ($58.25 Million) in capital expenditures ($2.54 Million). See ADMA Biologics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
$58.25 Million
USD
Capital Expenditures
$2.54 Million
USD
Data as of
Mar 2026
Most recent filing
ADMA Biologics Inc Capital Reinvestment Ratio (2023–2025)
This chart tracks ADMA Biologics Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for ADMA Biologics Inc (2023–2025)
Year-by-year Capital Reinvestment Ratio for ADMA Biologics Inc from 2023 to 2025. For live market cap and broader valuation context, see market cap of ADMA Biologics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | $50.40 Million | $22.57 Million | ▲ +519.9% |
| 2024 | 0.07x | $118.67 Million | $8.57 Million | ▼ -87.2% |
| 2023 | 0.57x | $8.80 Million | $4.98 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow